Matches in Nanopublications for { ?s ?p "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- NP467867.RA6kTkT35hwdvtyp1y7YWkQDbNldGwTMwyoQFt3tr7saE130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467867.RA6kTkT35hwdvtyp1y7YWkQDbNldGwTMwyoQFt3tr7saE130_provenance.
- NP798764.RAl5L3PMB0pFx8tbdLdAkv_gVOgALScUOfEUBWG7VCZbs130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798764.RAl5L3PMB0pFx8tbdLdAkv_gVOgALScUOfEUBWG7VCZbs130_provenance.
- NP549235.RAyQ6cASy1Sl4TY_sr9WRTxNcOW2aSosplOZ3Mi_EsCtk130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549235.RAyQ6cASy1Sl4TY_sr9WRTxNcOW2aSosplOZ3Mi_EsCtk130_provenance.
- NP462370.RA3SfgxRew6Gqh41xo_BNrYhYzBfqcyPrGddK_s6lNR5c130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462370.RA3SfgxRew6Gqh41xo_BNrYhYzBfqcyPrGddK_s6lNR5c130_provenance.
- NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869707.RAy7mv7Xym4ugfF1KaF6tBDPA1JR0h5d-zCt9kZZUb9bg130_provenance.
- NP825023.RA8T_Mn4hUayM8gATwLU1oapGj0A54q75mic3mDviaEdc130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825023.RA8T_Mn4hUayM8gATwLU1oapGj0A54q75mic3mDviaEdc130_provenance.
- NP811659.RAFAKyh3-oyyNXhOWxpfYCVtFWcF8M58oOdTSI2HuWn9c130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811659.RAFAKyh3-oyyNXhOWxpfYCVtFWcF8M58oOdTSI2HuWn9c130_provenance.